Literature DB >> 29428103

Risk factors and metabolic abnormality of patients with non-alcoholic fatty liver disease: Either non-obese or obese Chinese population.

Shou-Wu Lee1, Teng-Yu Lee2, Sheng-Shun Yang2, Chun-Fang Tung2, Hong-Zen Yeh2, Chi-Sen Chang2.   

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) occurs not only in obese individuals but also in non-obese ones. The aim of this study was to focus on the association between NAFLD and metabolic events in a non-obese or obese Chinese population.
METHODS: Data collected from subjects registered at Taichung Veterans General Hospital from January to December 2009 were analyzed. The exclusion criteria were alcoholics, chronic hepatitis B or C. Patients included in analyses were assigned to four groups according to sonography of their liver (normal or NAFLD), and body mass index (BMI) levels (non-obese if BMI < 25 kg/m2 or obese if BMI ≥ 25 kg/m2).
RESULTS: There were 745, 208, 770 and 285 patients enrolled in four groups labeled non-obese normal liver (group A), non-obese NAFLD (group B), obese normal liver (group C) and obese NAFLD (group D), respectively. The highest ratio of metabolic syndrome existed in the group B (26.9%), followed by group A (11.7%), group D (10.9%) and finally the group C (5.2%). The positive association with NAFLD in non-obese individuals was significant in triglyceride (OR = 1.01; 95% CI: 1.01-1.02) and glucose (OR = 1.02; 95% CI: 1.01-1.03), while the positive association with NAFLD in obese subjects was only significant in triglyceride (OR = 1.01; 95% CI: 1.01-1.02). The positive association was most significant in all cases (adjusted OR = 2.41; 95% CI: 1.78-3.24), especially in non-obese individuals (OR = 2.81; 95% CI: 1.92-4.12).
CONCLUSIONS: Non-obese NAFLD subjects displayed a higher proportion of metabolic abnormality. Hyperlipidemia and hyperglycemia had the most positive strength association with NAFLD.
Copyright © 2018 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chinese population; Fatty liver; Non-alcoholic fatty liver disease; Obese

Mesh:

Substances:

Year:  2018        PMID: 29428103     DOI: 10.1016/j.hbpd.2018.01.007

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  9 in total

1.  Effect of lipid metabolism disorder on liver function in patients with malignant tumors after chemotherapy: a case-control study.

Authors:  Yan Sun; Nie Zhang; Yun-Long Ding; Li-Jiang Yu; Jun Cai; Wu Yang; Wang-Kun Lu; Jia-Li Niu
Journal:  Lipids Health Dis       Date:  2019-05-10       Impact factor: 3.876

2.  Sex, Age, and BMI Modulate the Association of Physical Examinations and Blood Biochemistry Parameters and NAFLD: A Retrospective Study on 1994 Cases Observed at Shuguang Hospital, China.

Authors:  Zhengli Tang; Minh Pham; Yiming Hao; Fang Wang; Devashru Patel; Lori Jean-Baptiste; Lin Fan; Weijian Wang; Yiqin Wang; Feng Cheng
Journal:  Biomed Res Int       Date:  2019-06-24       Impact factor: 3.411

3.  The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Maryam Akbari; Omid Reza Tamtaji; Kamran B Lankarani; Reza Tabrizi; Ehsan Dadgostar; Neda Haghighat; Fariba Kolahdooz; Amir Ghaderi; Mohammad Ali Mansournia; Zatollah Asemi
Journal:  Lipids Health Dis       Date:  2020-02-17       Impact factor: 3.876

Review 4.  Role of Hepatokines in Non-alcoholic Fatty Liver Disease.

Authors:  Yini Ke; Chengfu Xu; Jin Lin; Youming Li
Journal:  J Transl Int Med       Date:  2019-12-31

5.  Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.

Authors:  Lampros Chrysavgis; Eleftheria Ztriva; Adonis Protopapas; Konstantinos Tziomalos; Evangelos Cholongitas
Journal:  World J Gastroenterol       Date:  2020-11-14       Impact factor: 5.742

6.  LDL/HDL cholesterol ratio is associated with new-onset NAFLD in Chinese non-obese people with normal lipids: a 5-year longitudinal cohort study.

Authors:  Yang Zou; Ling Zhong; Chong Hu; Mingchun Zhong; Nan Peng; Guotai Sheng
Journal:  Lipids Health Dis       Date:  2021-03-25       Impact factor: 3.876

7.  Dose-Response Associations of Metabolic Score for Insulin Resistance Index with Nonalcoholic Fatty Liver Disease among a Nonobese Chinese Population: Retrospective Evidence from a Population-Based Cohort Study.

Authors:  Xintian Cai; Jing Gao; Junli Hu; Wen Wen; Qing Zhu; Mengru Wang; Shasha Liu; Jing Hong; Ting Wu; Shunfan Yang; Guzailinuer Tuerxun; Nanfang Li
Journal:  Dis Markers       Date:  2022-02-23       Impact factor: 3.434

8.  Systolic Blood Pressure Mediates Body Mass Index and Non-alcoholic Fatty Liver Disease: A Population-Based Study.

Authors:  Xue Guan; Qian Zhang; Jie Xing; Shuohua Chen; Shouling Wu; Xiujing Sun
Journal:  Turk J Gastroenterol       Date:  2021-05       Impact factor: 1.852

9.  The Regulatory Effects of Citrus Peel Powder on Liver Metabolites and Gut Flora in Mice with Non-Alcoholic Fatty Liver Disease (NAFLD).

Authors:  Meiyi Hu; Li Zhang; Zheng Ruan; Peiheng Han; Yujuan Yu
Journal:  Foods       Date:  2021-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.